Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Malignant Melanoma

  Free Subscription


Articles published in Curr Opin Oncol

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    March 2025
  1. MARTIN FUENTES A
    The role of the microbiome in skin cancer development and treatment.
    Curr Opin Oncol. 2025;37:121-125.
    PubMed     Abstract available


    January 2025
  2. MOUNA O, Hanssens C, Meyers M, Langouo M, et al
    Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy.
    Curr Opin Oncol. 2025 Jan 16. doi: 10.1097/CCO.0000000000001118.
    PubMed     Abstract available


    December 2024
  3. MEYERS M, Mouna O, Langouo M
    Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?
    Curr Opin Oncol. 2024 Dec 30. doi: 10.1097/CCO.0000000000001119.
    PubMed     Abstract available


    March 2024
  4. PADONOU F, Vanhulst T, Langouo-Fontsa MD
    Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?
    Curr Opin Oncol. 2024;36:63-68.
    PubMed     Abstract available


    January 2024
  5. BENHIMA N, Belbaraka R, Fontsa ML
    Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence.
    Curr Opin Oncol. 2024 Jan 3. doi: 10.1097/CCO.0000000000001014.
    PubMed     Abstract available


    September 2023
  6. KINDT N, Kotecki N, Awada A
    Preclinical models to understand the biology and to discover new targets in brain metastases.
    Curr Opin Oncol. 2023;35:436-440.
    PubMed     Abstract available


    July 2023
  7. SAUDE-CONDE R, Nguyen D, Hendlisz A
    Immunotherapies in non-metastatic gastrointestinal cancers.
    Curr Opin Oncol. 2023;35:334-346.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.